Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Distribution of Selenium in Patients With Differentiated Thyroid Carcinoma and Effect of Selenium Supplement on Prognosis of Patients With Differentiated Thyroid Carcinoma.

NCT04683575 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT04683575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04683575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Distribution of Selenium in Patients With Differentiated Thyroid Carcinoma and Effect of Selenium Supplement on Prognosis of Patients With Differentiated Thyroid Carcinoma.
Lead sponsor
Qianfoshan Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
May 30, 2022
Completion date
December 31, 2025
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastasis, recurrence, selenium deficiency, thyroid cancer tnm staging